Final Overall Survival Results From the Phase 3 SOLO2 Trial for Ovarian Cancer

Final Overall Survival Results From the Phase 3 SOLO2 Trial for Ovarian Cancer

Prof. Hannah Simonds presents abstracts on ovarian cancerПодробнее

Prof. Hannah Simonds presents abstracts on ovarian cancer

Estudios Sobresalientes de ASCO 2020Подробнее

Estudios Sobresalientes de ASCO 2020

Dr. Zakashansky on the Benefit of Maintenance Olaparib in BRCA+ Ovarian CancerПодробнее

Dr. Zakashansky on the Benefit of Maintenance Olaparib in BRCA+ Ovarian Cancer

Dana Chase, MD, FACOG, on interpretations of the overall survival results of the Phase 3 SOLO2 studyПодробнее

Dana Chase, MD, FACOG, on interpretations of the overall survival results of the Phase 3 SOLO2 study

Joyce Liu, MD, on overall survival outcomes of Phase 3 SOLO2 study regarding advanced ovarian cancerПодробнее

Joyce Liu, MD, on overall survival outcomes of Phase 3 SOLO2 study regarding advanced ovarian cancer